C07C 50/26
Containing groups having oxygen atoms singly bound to carbon atoms
Official title: containing groups having oxygen atoms singly bound to carbon atoms
C07C50/26 (Containing groups having oxygen atoms singly bound to carbon atoms) appears on 280 US grants and 172 published applications in this corpus.
Search patents in C07C- Granted patents
- 280
- Published applications
- 172
- Assignees
- 187
- Inventors
- 718
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 8 | 0 |
| 1978 | 6 | 0 |
| 1979 | 8 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 9 | 0 |
| 1985 | 7 | 0 |
| 1986 | 6 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 18 | 0 |
| 1991 | 8 | 0 |
| 1992 | 11 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 3 |
| 2003 | 1 | 6 |
| 2004 | 7 | 8 |
| 2005 | 2 | 5 |
| 2006 | 0 | 7 |
| 2007 | 3 | 9 |
| 2008 | 2 | 7 |
| 2009 | 2 | 8 |
| 2010 | 7 | 8 |
| 2011 | 2 | 8 |
| 2012 | 5 | 7 |
| 2013 | 2 | 5 |
| 2014 | 5 | 3 |
| 2015 | 8 | 6 |
| 2016 | 7 | 3 |
| 2017 | 3 | 5 |
| 2018 | 5 | 4 |
| 2019 | 1 | 8 |
| 2020 | 6 | 6 |
| 2021 | 9 | 12 |
| 2022 | 3 | 12 |
| 2023 | 5 | 8 |
| 2024 | 6 | 13 |
| 2025 | 8 | 8 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 50/32The quinoid structure being part of a condensed ring system having two110
- C07C 50/28With monocyclic quinoid structure96
- C07C 50/34The quinoid structure being part of a condensed ring system having three36
- C07C 50/36The quinoid structure being part of a condensed ring system having four32
- C07C 50/30With polycyclic non-condensed quinoid structure29
Recent patents
- Co-crystal of coenzyme QH and nicotinamide, preparation method therefor and use thereof25 Aug 2026US 12,715,832 B2Cocrystal Technology (Jiaxing) Co., Ltd.
- Production method for reduced coenzyme Q10 form-II type crystal or crystalline solid thereof5 May 2026US 12,617,744 B2Kaneka Corporation
- Electroactive species and method for electrochemical gas separation4 Nov 2025US 12,458,922 B2Verdox, Inc.
- Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureus7 Oct 2025US 12,433,853 B2Kent State University
- Aqueous organic-based electrolyte for redox flow battery7 Oct 2025US 12,438,175 B2Kemiwatt
- Bromoquinone as a treatment for obesity and cancer30 Jul 2026US 2026/0216099 A1
- Compounds, compositions, methods of using, and methods for preparing compounds2 Jul 2026US 2026/0183260 A1The Institute for Stem Cell Biology and Regenerative Medicine (Instem)
- Crystal and formulation of reduced coenzyme q108 Jan 2026US 2026/0008739 A1Kaneka Corporation
- Compounds and methods for the treatment of parasitic infections25 Dec 2025US 2025/0387359 A1The Board of Trustees of the University of Illinois
- Production of oxygenated diterpenoid compounds21 Aug 2025US 2025/0263763 A1Københavns Universitet
Most cited
By later US patents
- Photodefinable polymers containing perfluorocyclobutane groups80US 5,426,164 AThe Dow Chemical Company · 1995
- Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity63US 4,794,188 AUSV Pharmaceutical Corporation · 1988
- Particles with modified physicochemical properties, their preparation and uses62US 6,197,349 B1Knoll, Inc. · 2001
- Ketone compounds and compositions for cholesterol management and related uses56US 6,699,910 B2Esperion Therapeutics, Inc. · 2004
- Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases41US 8,093,273 B2Resverlogix Corp. · 2012